Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05189314 · ClinicalTrials.gov registry record

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

A clinical trial of Thyroid Nodules, sponsored by Columbia University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05189314: Recruiting study of Thyroid Nodules, sponsored by Columbia University.

NCT05189314 is a study of Thyroid Nodules that is actively recruiting participants, run by Columbia University. The registered enrollment target is 100 participants, below the 150-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05189314, a study of Thyroid Nodules, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.

Primary Outcome

Percent Volume Change of Nodules: ((Volume (baseline) - Volume (\*m\*))/Volume(baseline))\*100

Conditions Studied

Interventions

  • PROCEDURE Thyroidectomy
  • DEVICE Radiofrequency Ablation

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-08-30
Est. Completion 2027-08
Columbia University

958 total trials

What NCT05189314 shows while recruiting

NCT05189314 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 150-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (33% lower).

The record links to 1 condition, with Thyroid Nodules appearing as the primary indexed condition, and to 2 interventions - of which Thyroidectomy is the first listed.

NCT05189314 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05189314 about?

NCT05189314 is a clinical study titled "RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study". The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their ...

What is the current status of trial NCT05189314?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2019-08-30. Estimated completion is 2027-08.

What conditions does trial NCT05189314 study?

This clinical trial studies the following conditions: Thyroid Nodules.

What interventions are being tested in trial NCT05189314?

The interventions under investigation include: Thyroidectomy (PROCEDURE), Radiofrequency Ablation (DEVICE).

Who is sponsoring clinical trial NCT05189314?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05189314 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Nodules

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05189314, the US trial registry maintained by the National Library of Medicine. NCT05189314 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.